Results 71 to 80 of about 62,464 (165)

Stakeholders' perspectives on HIV prevention in the Czech Republic: a qualitative study. [PDF]

Front Public Health
Szépe V, Rödlová S, Zlámal M, Tichopád A.   +3 more
europepmc   +1 more source

Access to Medicines in Bulgaria and North Macedonia: Legislative, Pricing, and Reimbursement Perspectives. [PDF]

Pharmacy (Basel)
Todorova A, Miceva D, Ivanova M, Kazakova T, Angelovska B.   +4 more
europepmc   +1 more source

Advancing health technology assessment in Taiwan: over 15 years of evidence-based reform, innovation, and patient partnership. [PDF]

Int J Technol Assess Health Care
Huang LY, Lin SY, Liu MH.
europepmc   +1 more source

Access barriers to in vitro diagnostics in Cambodia, Indonesia, Lao PDR, and the Philippines: programmatic lessons from NEDL field missions. [PDF]

Trop Med Health
Kanamori S, Evangelista NM, Marayag NG, Ramones RAJ, Sokunna S, Muniarti W, Khamphaphongphane B, Vonghachack Y, Villanueva AFDR, Uechi M, Egami Y, Hashimoto N, Shimizu E, Norizuki M, Fujita M.   +14 more
europepmc   +1 more source

The Enactment and Implementation of Korea's Digital Medical Products Act: A Comparative Study Exploring Policy Implications. [PDF]

J Korean Med Sci
Chung J, Shin Y, Kim G, Lee M, Shin J.
europepmc   +1 more source

Impact of expanded pediatric surgery add-on payments on claimed surgical fees: a multi-institutional data analysis. [PDF]

Ann Surg Treat Res
Son J, Lee S, Park S, Kim W, Kim W, Seo JM, Oh C.   +6 more
europepmc   +1 more source

Policy and Payment Factors Influencing Adoption of Low-Barrier Buprenorphine Treatment.

JAMA Netw Open
Lowenstein M, Holliday Davis M, Suhail-Sindhu S, McMurtrie G, Grande D, Hinckley J, Aronowitz SV.   +6 more
europepmc   +1 more source

Financial reimbursement for clinical trial participation costs: a pilot feasibility study. [PDF]

JNCI Cancer Spectr
Williams CP, Henderson NL, Jahan N, Stringer-Reasor E, Azuero A, Pisu M, Arend RC, Rocque GB.   +7 more
europepmc   +1 more source

The "China model" for rare disease governance: Policy framework, local implementation, and pathways for optimization. [PDF]

Intractable Rare Dis Res
Zhang X, Luan J, Mu Y, Zhang K, Han Z, Han J.   +5 more
europepmc   +1 more source

Policy Levers for First-Contact Healthcare Provider Choice: A Discrete Choice Experiment in Shanghai's Hierarchical Medical System. [PDF]

Appl Health Econ Health Policy
Gong Y.
europepmc   +1 more source